WallStreetZenWallStreetZen

NYSE: TEVA
Teva Pharmaceutical Industries Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TEVA

Based on 8 analysts offering 12 month price targets for Teva Pharmaceutical Industries Ltd

Min Forecast
$40.00+11.08%
Avg Forecast
$42.00+16.63%
Max Forecast
$45.00+24.97%

Should I buy or sell TEVA stock?

Based on 8 analysts offering ratings for Teva Pharmaceutical Industries Ltd.

Strong Buy
Strong Buy
7 analysts 87.5%
Buy
1 analysts 12.5%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TEVA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates TEVA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their TEVA stock forecasts and price targets.

TEVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-06
lockedlocked$00.00+00.00%2026-04-30
lockedlocked$00.00+00.00%2026-04-30Find Out Why
lockedlocked$00.00+00.00%2026-04-30Find Out Why
lockedlocked$00.00+00.00%2026-04-30Find Out Why
Bank of America
Top 13%
88
Strong BuyMaintains$42.00+16.63%2026-04-09Find out why
Goldman Sachs
Top 40%
61
Strong BuyMaintains$45.00+24.97%2026-02-09
ScotiaBank
Top 18%
83
BuyMaintains$40.00+11.08%2026-01-29

1 of 1

TEVA vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
TEVA$36.01$42.00+16.63%Strong Buy
HLN$9.30N/AN/A
ZTS$87.31$143.88+64.79%Buy
TAK$16.64N/AN/A
VTRS$17.39$14.50-16.62%Buy
View Top Pharmaceutical Stocks

Teva Pharmaceutical Industries Stock Forecast FAQ

Is Teva Pharmaceutical Industries Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NYSE: TEVA) stock is to Strong Buy TEVA stock.

Out of 8 analysts, 7 (87.5%) are recommending TEVA as a Strong Buy, 1 (12.5%) are recommending TEVA as a Buy, 0 (0%) are recommending TEVA as a Hold, 0 (0%) are recommending TEVA as a Sell, and 0 (0%) are recommending TEVA as a Strong Sell.

If you're new to stock investing, here's how to buy Teva Pharmaceutical Industries stock.

What is TEVA's Price Target?

According to 8 Wall Street analysts that have issued a 1 year TEVA price target, the average TEVA price target is $42.00, with the highest TEVA stock price forecast at $45.00 and the lowest TEVA stock price forecast at $40.00.

On average, Wall Street analysts predict that Teva Pharmaceutical Industries's share price could reach $42.00 by May 6, 2027. The average Teva Pharmaceutical Industries stock price prediction forecasts a potential upside of 16.63% from the current TEVA share price of $36.01.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.